Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/publications/7117-do-all-patients-with-advanced-her2-positive-breast-cancer-need-upfront-chemo-when-receiving-trastuzumab-randomized-phase-iii-trial-sakk-2299
https://forschung.kssg.ch/de/publications/7117-do-all-patients-with-advanced-her2-positive-breast-cancer-need-upfront-chemo-when-receiving-trastuzumab-randomized-phase-iii-trial-sakk-2299